Skip to Content

Medications for Deep Vein Thrombosis, Prophylaxis

About Deep Vein Thrombosis, Prophylaxis

Pharmacological and non-pharmacological measures taken to prevent blood from clotting in the veins

Drugs used to treat Deep Vein Thrombosis, Prophylaxis

The following list of medications are in some way related to, or used in the treatment of this condition.

Drug name Rating Reviews Activity ? Rx/OTC Pregnancy CSA Alcohol
enoxaparin 6.8 5 reviews
Rx B N

Generic name: enoxaparin systemic

Brand name:  Lovenox

Drug class: heparins

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information

Lovenox 6.8 4 reviews
Rx B N

Generic name: enoxaparin systemic

Drug class: heparins

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

Xarelto 7.0 8 reviews
Rx C N

Generic name: rivaroxaban systemic

Drug class: factor Xa inhibitors

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

Eliquis 3.8 8 reviews
Rx B N

Generic name: apixaban systemic

Drug class: factor Xa inhibitors

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

Arixtra 8.0 1 review
Rx B N

Generic name: fondaparinux systemic

Drug class: factor Xa inhibitors

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

heparin 1.0 1 review
Rx C N

Generic name: heparin systemic

Drug class: heparins

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information

rivaroxaban 7.0 8 reviews
Rx C N

Generic name: rivaroxaban systemic

Brand name:  Xarelto

Drug class: factor Xa inhibitors

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph

apixaban 3.8 8 reviews
Rx B N

Generic name: apixaban systemic

Brand name:  Eliquis

Drug class: factor Xa inhibitors

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information

Fragmin 0.0 1 review
Rx B N

Generic name: dalteparin systemic

Drug class: heparins

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

fondaparinux 8.0 1 review
Rx B N

Generic name: fondaparinux systemic

Brand name:  Arixtra

Drug class: factor Xa inhibitors

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information

dalteparin 0.0 1 review
Rx B N

Generic name: dalteparin systemic

Brand name:  Fragmin

Drug class: heparins

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph

Iprivask Rate Add review
Rx C N

Generic name: desirudin systemic

Drug class: thrombin inhibitors

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

dabigatran 5.0 3 reviews
Rx C N

Generic name: dabigatran systemic

Brand name:  Pradaxa

Drug class: thrombin inhibitors

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information

Pradaxa 5.0 2 reviews
Rx C N

Generic name: dabigatran systemic

Drug class: thrombin inhibitors

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

desirudin Rate Add review
Rx C N

Generic name: desirudin systemic

Brand name:  Iprivask

Drug class: thrombin inhibitors

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph

Topics under Deep Vein Thrombosis, Prophylaxis

Legend

Rating For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective).
Activity Activity is based on recent site visitor activity relative to other medications in the list.
Rx Prescription Only.
OTC Over the Counter.
Rx/OTC Prescription or Over the Counter.
Off-label This medication may not be approved by the FDA for the treatment of this condition.
Pregnancy Category
A Adequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters).
B Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.
C Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
D There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
X Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use in pregnant women clearly outweigh potential benefits.
N FDA has not classified the drug.
Controlled Substances Act (CSA) Schedule
N Is not subject to the Controlled Substances Act.
1 Has a high potential for abuse. Has no currently accepted medical use in treatment in the United States. There is a lack of accepted safety for use under medical supervision.
2 Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence.
3 Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence.
4 Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3.
5 Has a low potential for abuse relative to those in schedule 4. Has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 4.
Alcohol
X Interacts with Alcohol.

Browse Treatment Options

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.